NEUROGENE

Trademark usage description

pharmaceutical preparations for the prevention of disorders of the nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sen Read More

Classification Information

Class [005]
Pharmaceutical preparations for the prevention of disorders of the nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations for the prevention of central nervous system [CNS] disorders; pharmaceutical preparations for preventing peripheral nervous system disorders;

Classification kind code

Class [042]
Pharmaceutical drug development services; Pharmaceutical research services; Research and development in the medical biotechnology field

Classification kind code

Mark Details

Serial Number

2112919

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 42 on 8^th Jan 2025	Advertised
Submitted for opposition 27 on 12^th Dec 2024	Approval Notice Sent
Submitted for opposition 26 on 12^th Dec 2024	Approved
Submitted for opposition 22 on 4^th Dec 2024	Search Recorded
Submitted for opposition 287 on 5^th Jul 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 9^th Jun 2021	Filed
Submitted for opposition 1 on 9^th Jun 2021	Created
Submitted for opposition 31 on 9^th Jun 2021	Formalized

NEUROGENE

Classification Information

Classification kind code

Class [042]Pharmaceutical drug development services; Pharmaceutical research services; Research and development in the medical biotechnology field

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [042]
Pharmaceutical drug development services; Pharmaceutical research services; Research and development in the medical biotechnology field